Ramakrishna Nirogi
17PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (17)
Sort by Publication Date:
|May 23, 2025
Resveratrol, a calorie restriction mimetic, protects AlCl<sub>3</sub>-induced neurotoxicity and cognitive deficits in rats via inhibition of oxidative stress.Vijay S Benade, Pradeep Jayarajan, Nandakumar Krishnadas
|Feb 02, 2025
Correction: Determination of Intrinsic Clearance and Fraction Unbound in Human Liver Microsomes and In Vitro-In Vivo Extrapolation of Human Hepatic Clearance for Marketed Central Nervous System Drugs.Veera Raghava Chowdary Palacharla, Ramakrishna Nirogi, Nitesh Kumar
|Dec 26, 2024
Determination of Intrinsic Clearance and Fraction Unbound in Human Liver Microsomes and In Vitro-In Vivo Extrapolation of Human Hepatic Clearance for Marketed Central Nervous System Drugs.Veera Raghava Chowdary Palacharla, Ramakrishna Nirogi, Nitesh Kumar
|Dec 29, 2023
Bioequivalence, food effect and comparative pharmacokinetics of SUVN-1105, a novel granule formulation of abiraterone acetate, to Zytiga in healthy male subjects.Ramakrishna Nirogi, Jyothsna Ravula, Vijay Benade
|Aug 13, 2022
Safety, Tolerability, and Pharmacokinetics of Ropanicant (SUVN-911), a Novel Alpha4 Beta2 Nicotinic Acetylcholine Receptor (α4β2 nAChR) Antagonist, in Healthy Adult and Elderly Subjects.Ramakrishna Nirogi, Vijay Benade, Vinod Kumar Goyal
|Nov 11, 2021
1-[2-(1-Cyclobutylpiperidin-4-yloxy)-6,7-dihydro-4H-thiazolo[5,4-c]pyridin-5-yl]propan-1-one: a Histamine H<sub>3</sub> Receptor Inverse Agonist with Efficacy in Animal Models of Cognition.Anil Karbhari Shinde, Rajesh Kumar Badange, Veena Reballi
Pageof 3
